The company reported high marks across several quality categories, including a five-star rating for medication reviews in its care for older adults programs. Functional status assessments for the same demographic earned 4.03 stars, while the company’s track record on all-cause readmissions—a metric tracking unplanned hospital returns—reached 4.77 stars.
In section Market Quotes
Aetna Secures Strong Star Ratings for 2027 Medicare Advantage Plans
Roughly 69% of Aetna’s Medicare Advantage members are enrolled in plans rated four stars or higher for 2027, according to CVS Health. The Centers for Medicare & Medicaid Services evaluates these insurance offerings annually, with Aetna’s latest performance metrics highlighting notable gains in patient care and clinical oversight.
Beyond clinical outcomes, Aetna maintained ratings above four stars in consumer-facing areas such as healthcare quality, customer service, and grievance management regarding drug plans. Despite these operational results, CVS Health shares fell 2.7% to $85.47 in after-hours trading following the announcement.
Comments (0)
No comments yet. Be the first!